China Medical Technologies Invests $345 Million In HPV Genotyping Chip
This article was originally published in The Gray Sheet
Executive Summary
China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year